This study investigates the use of an AI system in the management of pancreatic diseases. The AI system analyzes contrast-enhanced CT scans to assist in making clinical decisions.
The study evaluates the safety and accuracy of the AI system in comparison to traditional clinical decisions. It focuses on the AI's ability to correctly classify patients and improve decision-making for pancreatic conditions.
- Who can participate: Adults scheduled for contrast-enhanced CT for suspected pancreatic disease and who have provided informed consent can participate. Exclusions include those with a history of pancreatic surgery or contraindications to CT contrast.
- Study details: Participants will undergo contrast-enhanced CT scans, and the AI system will classify their condition. The AI's classifications will be compared to decisions made by clinical doctors.